Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	16.68	236.30	202.52
Graham Fair Price	-3.27	37.01	38.26
PEG	471.68	-6.12	1.07
Price/Book	12.00	10.00	8.93
Price/Cash Flow	-19.88	-687.28	-573.28
Prices/Earnings	30.73	64.04	48.99
Price/Sales	19.86	73.83	61.60
Price/FCF	-19.88	-687.28	-573.28
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.56	0.66	0.66
Operating Margin	6.34	0.25	0.23
ROA	-12.31	0.03	0.04
ROE	0.05	0.04	-14.33
ROIC	0.04	0.04	-12.28
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-1.00	0.00	-100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.03	0.04	27.34
EPS QOQ	0.46	-0.10	-77.13
FCF QOQ	-1.71	0.02	-98.84
Revenue QOQ	0.11	-0.02	-81.53
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	168.77	181.24	7.39
Days Sales Outstanding (DSO)	59.16	60.00	1.42
Inventory Turnover	0.53	0.50	-6.88
Debt/Capitalization	< 0.005	-0.03	-654.63
Quick Ratio	3.91	4.41	12.63
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	37.79	39.50	4.51
Cash	14.83	13.58	-8.46
Capex	-1.24	-0.68	44.67
Free Cash Flow	-0.59	-0.57	2.37
Revenue	5.48	5.35	-2.34
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.76	5.55	16.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.64	-4.91	-5.76
Naive Interpretation	Member

06 - Financial Health · Bad

Rating